Skip to content

Clinical trials

Phase 2/3 Recurrence trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Phase 2/3 Country / region: United Kingdom Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20161
20171
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting2
Completed2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen1
BioNTech SE1
Celgene1
Geron Corporation1
Kiniksa Pharmaceuticals International, plc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence5
Head and Neck Neoplasms1
Leukemia1
Lymphoma, B-Cell1
Lymphoma, Large B-Cell, Diffuse1
Lymphoma, Non-Hodgkin1
Myelodysplastic Syndromes1
Neoplasm Metastasis1
Neoplasms1
Pericarditis1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.